Pharma Deals Review, Vol 2010, No 5 (2010)

Font Size:  Small  Medium  Large

Intercell Acquires Monoclonal Antibody Assets from Cytos

Debbie Tranter

Abstract


Cytos is to transfer its monoclonal antibody (mAb) technology platform, a specific application of the so-called DELphi™ technology, to Intercell for EUR 15 M.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.